Program 2017

Location Note:

 

Neuroethics Network sessions will be held at:

ICM, (Institut du Cerveau et de la Moelle Épinière)

47 boulevard de l’hôpital, CHU Pitié-Salpêtrière , 75013, Paris, France

 

•••••••••••••••••••••••••••••••••••••••••

 

Monday, June 19

 

 

1:00-1:15 PM        Welcome

                                Yves Agid, MD, PhD, ICM, Hôpital Pitié Salpêtrière, Paris -- FRANCE

 

 

1:15-1:45 PM        Charting Unknown Territory: What Do Advances in Brain Mapping Mean? and

                                How Should We Evaluate the Reportedly High Rate of False Positives in fMRI Results?

 

                                  Jérome Yelnik, MD, PhD, ICM – FRANCE and

                                 Stephane Lehericy, MD, PhD, ICM, Hôpital Pitié Salpêtrière, Paris -- FRANCE

 

 

1:45-2:00 PM       Implications of the Methodological Crisis in Neuroimaging

                                  Philipp Kellmeyer, MD, PhD, Department of Neurology, University of Freiburg -- GERMANY

 

 

2:00-2:30 PM      Group Discussion

 

 

2:30-3:30 PM      No Neuro-nonsense: The Need to Separate Fact from Fantasy

                                  Moderator: James Giordano, PhD,  Neuroethics                                                                                                                                                                        

                                  Studies Program, Edmund D. Pellegrino Center for Clinical Bioethics, Georgetown University Medical Center,

                                  Washington, DC, USA

 

 

Speakers:             Collective Memory: A Double-Edged Sword

                                  Laura Spinney, Science Writer, Paris -- FRANCE

 

                                  I’ve Seen Things You People Wouldn’t Believe: The Role of Film and Fiction in Neuroscience and Neuroethics

                                  David Lawrence, PhD, New Castle Law School, New Castle University – UNITED KINGDOM

 

 

                                  The Poetry and the Passion

                                  John Harris, FMedSci, D.Phil. Emeritus Professor, The Institute for Science, Ethics and Innovation, School of Life

                                  Sciences, University of Manchester, UNITED KINGDOM

 

 

3:30-3:45 PM       Group Discussion

 

 

3:45-4:15 PM        NETWORKING SESSION

                                Coffee and Pâtisserie

 

 

4:15-4:45 PM        Side Stepping the Hard Problem? How to Deal with the “Puzzle of Consciousness” in Clinical Contexts

                                  What does it mean if we image activity in brain areas identified to be functional in consciousness in the nonverbal

                                  patient? What does this information compel: Ethically?  Legally?  Socially? Should we – or how much should we –

                                  devote  funds to neuroscience and technology in order to access subjective consciousness?

 

                                  Speakers:  Lionel Naccache, MD, PhD, ICM and Department of Neurology, Pitié-Salpêtrière Hospital, Paris, FRANCE

 

                                 Joseph J. Fins, MD, Weill Cornell Medical College

                                  Division of Medical Ethics, New York, New York -- USA

 

 

4:45-5:15 PM        Group Discussion

 

 

5:15-6:00 PM       ICM Field Trip

                                Thought-Scribing

 

 

6:00-7:00 PM      Keynote Address

                                 Jean Claude Ameisen, MD, PhD, President, Franch National Consultative Committee (CCNE) Paris, FRANCE

 

 

•••••••••••••••••••••••••••••••••••••••••

 

 

Tuesday, June 20

 

8:15 AM                   Welcome coffee

 

8:45-9:00 AM       Yves Agid, MD, PhD, ICM, Hôpital Pitié Salpêtrière, Paris, FRANCE

 

 

9:00-9:45 AM      From Bench to Bench: What Does the Law Want to Know from Neuroscience?

 

 

                                     Making a Murderer: Do the Clues Lead to Connectivity of Brain Lesions?

 

                                  Can determining causal associations between brain lesions and criminal behavior influence the responsible

                                  use of neuroimaging in the courtroom?

                                  Ryan Darby, MD, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts  -- USA

 

 

                                     What Can Neuroscience Tell Us about Assessing the Reliability of Witnesses Recollections?

                                  Colin Gavaghan, PhD, New Zealand Law Foundation Centre for Law and Policy in Emerging Technologies,

                                  University of Otago, Dunedin -- NEW ZEALAND

 

 

9:45-10:15 AM     Group Discussion

 

10:15-11:00 AM   NETWORKING SESSION

                                  Coffee and Pâtisserie

 

11:00- 11:45 AM   Gene Hacking: Where are We?  Where Should We Be Going?

 

                                     Public Opinion on the Use of Gene Editing

                                  Cary Funk, Associate Director of Research on Science and Society, Pew Research Center Washington, DC, USA

 

                                     Neuro-Hacking and Implications for International Public Safety

                                   James Giordano, PhD, Neuroethics Studies Program, Edmund D. Pellegrino Center for Clinical Bioethics,

                                  Georgetown University Medical Center, Washington, DC, USA

 

                                  CRISPR and Commercialization: Considering the Possibilities and Consequences

                                  Kevin Fitzgerald, SJ, PhD, Department of Molecular Genetics and Pellegrino Center for Clinical Bioethics,

                                  Georgetown University Medical Center, Washington, DC, USA

 

11:45-12:15 PM    Discussion: Gene Editing or the Life-Saving Bacon Sandwich: Some Problems and Possibilities for Hackers

 

                                  John Harris, FMedSci, D.Phil. Emeritus Professor, The Institute for Science, Ethics and Innovation,

                                  School of Life Sciences, University of Manchester, United Kingdom

 

                                  Pierre Jouannet, MD,  Emeritus Professor, University of Paris and a member of the National Academy of medicine

                                  and the Ethics Committee of INSERM (French National Institute of Health and Medical Research), FRANCE

 

 

12:15-1:15 PM       Lunch and Class Photo

 

 

1:15-2:15 PM        The Silent Stage of Alzheimer’s: Progression, Prediction and Responsibilities

 

                                Diagnosing Alzheimer’s Disease:  With Certainty? Pre-Clinically?

                                Bruno Dubois, MD, PhD, ICM, and Institute of Memory and Alzheimer Disease Hôpital Pitié Salpêtrière,

                                Paris, FRANCE

 

                                  Assisting Physicians to Recognize Subclinical Impairment,

                                  Catherine Madison, MD, Ray Dolby Brain Health Center,

                                  Sutter Health, California Pacific Medical Center, San Francisco, California, USA

 

 

2:15-2:45 PM        Group Discussion

 

 

2:45-3:30 PM       How Might the Development of Predictive Biomarkers Change the Extent of the Obligations We Owe to Others?

 

                                    How Much Should We Be Required to Know about the Risks Our Neurobiologies Pose to Others Given that the

                                     Development of Biomarkers, Algorithms, and Machine Learning Tools is Posed to Massively Expand the Domain of

                                     What We Could Know?

 

                                  Moderator: Matthew Baum, DPhil, MD-PhD (C)

                                  Harvard-MIT Division of Health Science & Technology, Division of Medical Sciences Program in Neuroscience,                                                                                                    

                                  Harvard Medical School, Boston, Massachusetts, USA

 

                                  Speakers:

                                  Alexandra Durr, MD, PhD, ICM and Department of Genetics, Pitié-Salpêtrière Hospital. Paris, FRANCE

                                  Hervé Chneiweiss, MD, PhD, French Institute of Health and Medical Research (INSERM), Paris, FRANCE

 

 

 

3:30-5:00 PM       “Cinema du Cerveau”

 

                                  IRIS

                                  “Iris” is the true story of revered British writer and philosopher Iris Murdoch, depicting her lifelong romance with

                                  her husband John Bayley, from their student days at Oxford through her battle with Alzheimer’s disease.

                                  Starring : Judi Dench, Kate Winslet, and James Broadbent.

 

5:00-5:45 PM       Panel Commentaries:

 

                                  Alexandra Durr, MD, PhD, ICM and Department of Genetics, Pitié-Salpêtrière Hospital. Paris, FRANCE

 

                                  Hervé Chneiweiss, MD, PhD, French Institute of Health and Medical Research (INSERM), Paris, FRANCE

 

                                  Catherine Madison, MD Catherine Madison, MD, Ray Dolby Brain Health Center,

                                  California Pacific Medical Center, San Francisco, California, USA

 

5:45-6:15 PM        Audience Discussion

 

6:15-7:00 PM        Cocktail Reception and Jazz Concert

                                  Music for the Mind

                                  Jérome Yelnik, MD, PhD, ICM, and his quartet

 

 

•••••••••••••••••••••••••••••••••••••••••

 

Wednesday, June 21

 

8:15 AM                   Welcome Coffee

 

8:45-9:00 AM      Yves Agid, MD, PhD, ICM, Hôpital Pitié Salpêtrière, Paris, FRANCE

 

9:00-9:30 AM     Sports Concussion and Cognitive Personality Change: Our Ethical Duties Grant Gillett, PhD, Otago Bioethics Centre,

                                  University of Otago Medical School, Dunedin, NEW ZEALAND

 

9:30-10:00 AM    Group Discussion

 

10:00-10:30 AM  NETWORKING SESSION

                                 Coffee and Pâtisserie

 

10:30-11:15 AM    New Horizons – and Beyond – in Neural Interface

                                Part One: In the Clinic

 

 

                                 “Get Up and Walk” Film with commentary

                                  Alim-Louis Benabid, MD, PhD, Emeritus Professor University of Grenoble and Founder and Board Chairman,

                                  Clinatec – The Edmond J. Safra Biomedical Research Center in Grenoble, FRANCE

 

                                  Neuroprosthetic technology for Speech: Ethical and Philosophical Questions

                                  Hannah Maslen, PhD, University of Oxford

                                  Oxford Uehiro Centre for Practical Ethics, Oxford University – UNITED KINGDOM

 

 

                                  The Neuroethical Future of Mobile and Wearable Technology, Karola Kreitmair, PhD,

                                  Center for Biomedical Ethics, Stanford University, Palo Alto, California – USA

 

11:15-11:45 AM     Group Discussion

 

 

11:45-12:30 PM   New Horizons – and Beyond – in Neural Interface,

                                     Part Two: Research, Policy, and Public Perception

 

 

                                    Neurolinks

                                  James Giordano, PhD,  Neuroethics Studies Program, Edmund D. Pellegrino Center for Clinical Bioethics, Georgetown

                                  University Medical Center, Washington, DC, USA

 

 

                                  Responsible Algorithmics: On the Ethics of Machine Learning in Neuroscience

                                  Philipp Kellmeyer, MD, PhD, Department of Neurology, University of Freiburg -- GERMANY

 

 

                                     Between Stop-signs and Guidelines: Navigating the Ethics of Experimental DBS-Applications

                                  Sven Nyholm, PhD, Department of Philosophy and Ethics, School of Innovation Sciences,

                                  Eindhoven University of Technology, THE NETHERLANDS

 

 

12:30-1:00 PM     Group Discussion

 

1:00-2:00 PM       Lunch

 

2:00-2:15 PM       Public Perspectives on the Potential for Cognitive Enhancement from Brain Chip Implants

                                  Cary Funk, Associate Director of Research on Science and Society,

                                  Pew Research Center - Washington, DC, USA

 

2:15-2:30 PM        (Brain) Machines, Interfaces, and Environments

                                  Tom Buller, PhD, Department of Philosophy, Illinois State University, Normal, Illinois, USA

 

2:30-3:00 PM       Group Discussion

 

 

3:00 PM                 Champagne

 

Au Revoir !

 

 

•••••••••••••••••••••••••••••••••••••••••

 

 

Neuroethics Network Posters 2017

 

The posters are on display throughout the meeting and can be viewed on the TV monitors, along with accompanying iPads.  Poster authors’ badges are marked with a red dot for easy identification.

 

 

Proportionality as a Guiding Principle for Regulating Neurotechnological Medical Devices

Philipp Kellmeyer, MD, PhD, Department of Neurology, University of Freiburg – GERMANY

 

More Human than Human

David Lawrence, New Castle Law School, New Castle University – UNITED KINGDOM

 

Revolution and Evolution -- From Philosophy to Neuroethics in the Curriculum

Michael DeWilde, Department of Philosophy, Allendale, Michigan, USA

 

The Clinical Neuroethics Initiative

Guillermo A. Palchik, PhD, Thomasine Kushner, PhD, and Alan H. Yee, DO, Sutter Health, California Pacific Medical Center, San Francisco, California, USA

 

The Physicalist Paradox: Neuroethical Proscriptions and Free Will in Jurisprudence

Denis Larrivee, Neiswanger Bioethics Institute, Loyola University Chicago, USA

Angeline Larrivee, Cornell U Department of Law, Ithaca, NY USA

 

Responsible Algorithmics: On the Ethics of Machine Learning in Neuroscience

Philipp Kellmeyer MD, PhD, Department of Neurology, University of Freiburg -- GERMANY

 

The Recognition of a New Classification for Neuroethics

M. Kalkach-Aparicio and S. Libien-Velázquez,  Anahuac University, Mexico City, MEXICO

 

A Definition for Clinical Neuroethics

M. Kalkach-Aparicio and A.M. Gutiérrez-Juárez, Anahuac University, Mexico City, MEXICO

 

Breaching Markhov's Blanket: Self Contextualization and Normative Envelopes

Denis Larrivee. Neiswanger Institute Bioethics. Loyola U Chicago, USA

 

Brain, Consciousness and Self: Some Neurophilosophical and Neuroethical Issues

Arleen Salles and Michele Farisco, CRB, Uppsala University, SWEDEN

 

Constructionist Framework: A New Model for Determining Criminal Responsibility in Patients with Frontotemporal Dementia (FTD)

R. Ryan Darby, MD, Judith Edersheim, MD, JD, Bruce H. Price, MD, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts,USA

 

Public Confidence in Scientists and Other Groups to Act in the Public Interest

Cary Funk, Pew Research Center, Washington, DC, USA